Raymond James Financial restated their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC - Free Report) in a research note published on Thursday, Marketbeat.com reports. Raymond James Financial currently has a $26.00 price target on the stock, down from their previous price target of $40.00.
A number of other research analysts have also weighed in on ACHC. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. UBS Group reduced their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Guggenheim reduced their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday, August 7th. KeyCorp reduced their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Finally, Stephens raised Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Five analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $40.77.
Read Our Latest Analysis on ACHC
Acadia Healthcare Stock Performance
ACHC traded up $0.32 during trading hours on Thursday, hitting $20.98. The stock had a trading volume of 2,135,757 shares, compared to its average volume of 2,429,440. The company's fifty day simple moving average is $21.97 and its 200 day simple moving average is $26.94. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $82.40. The stock has a market cap of $1.94 billion, a PE ratio of 13.89, a price-to-earnings-growth ratio of 4.08 and a beta of 0.88. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same quarter last year, the firm posted $0.91 EPS. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. Equities analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.
Institutional Trading of Acadia Healthcare
Hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after buying an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new stake in Acadia Healthcare in the 1st quarter worth approximately $222,000. Sterling Capital Management LLC lifted its position in Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after buying an additional 2,026 shares during the last quarter. Raiffeisen Bank International AG lifted its position in Acadia Healthcare by 33.3% in the 1st quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock worth $4,819,000 after buying an additional 40,000 shares during the last quarter. Finally, Teacher Retirement System of Texas bought a new stake in Acadia Healthcare in the 1st quarter worth approximately $412,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.